405,246 Shares in The Cooper Companies, Inc. $COO Purchased by Norges Bank

Norges Bank purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, Holdings Channel reports. The fund purchased 405,246 shares of the medical device company’s stock, valued at approximately $33,214,000.

Several other institutional investors also recently added to or reduced their stakes in COO. Bell Investment Advisors Inc increased its stake in Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares during the period. CYBER HORNET ETFs LLC purchased a new position in Cooper Companies in the 2nd quarter worth about $36,000. True Wealth Design LLC increased its stake in Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after buying an additional 383 shares during the period. Cromwell Holdings LLC increased its stake in Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after buying an additional 273 shares during the period. Finally, Board of the Pension Protection Fund purchased a new position in Cooper Companies in the 4th quarter worth about $41,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

COO has been the topic of several recent analyst reports. Needham & Company LLC reduced their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday. Robert W. Baird cut their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday. BNP Paribas Exane cut their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday. Finally, JPMorgan Chase & Co. cut their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Cooper Companies has a consensus rating of “Hold” and a consensus target price of $82.64.

Cooper Companies Trading Down 0.8%

NASDAQ COO opened at $66.79 on Tuesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The company has a market capitalization of $13.03 billion, a price-to-earnings ratio of 56.60, a price-to-earnings-growth ratio of 1.73 and a beta of 0.88. The company’s 50-day simple moving average is $64.99 and its two-hundred day simple moving average is $74.50. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period last year, the business earned $0.96 EPS. The company’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.